CWBR — CohBar Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
CohBar Inc reports results for the quarter ended in September - Earnings Summary
Brief: CohBar Reports Q3 Loss Per Share $0.05
CohBar Inc expected to post a loss of 8 cents a share - Earnings Preview
Brief: Cvi Investments Inc Reports 6.0% Passive Stake In Cohbar Inc
Brief: Cohbar Announces Pricing Of $15 Mln Public Offering Of Common Stock And Warrants
Brief: CohBar Announces Proposed Public Offering Of Common Stock And Warrants
Brief: CohBar Announces CB4211 Phase 1A/1B Results Selected For Late Breaker Presentation At Liver Meeting 2021
Brief: CohBar Appoints Joanne Yun to Its Board of Directors
Brief: CohBar Gets U.S. Patent Covering CB4211 Compositions, Use For Treating Nonalcoholic Steatohepatitis (NASH)
U.S. STOCKS ON THE MOVE-WW International, AppHarvest, CohBar
U.S. STOCKS ON THE MOVE-CohBar, HyreCar, Wix.com
U.S. STOCKS ON THE MOVE-CohBar, Good Times Restaurants, HyreCar
CohBar set to open at near 6-month high as early-stage NASH study hits main goal
CohBar Inc reports results for the quarter ended in June - Earnings Summary
Brief: CohBar Reports Second Quarter 2021 Financial Results And Provides Business Update
Brief: CohBar Announces Positive Topline Results From Phase 1A/1B Study Of CB4211 Under Development For Nash And Obesity
CohBar Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: CohBar Provides Update On Phase 1A/1B Clinical Trial For CB4211 Under Development For NASH And Obesity
CohBar Inc reports results for the quarter ended in March - Earnings Summary